InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Thomas Jonassen. Director active across 1 company, notably SynAct Pharma AB. Aggregated, 3 disclosures have been recorded. Activity tracked since 6 January 2021. The latest transaction was disclosed on 6 January 2021 (Other). Regulator: FIN-FSA. The full history is free.
3 of 3 declarations